IDiyas

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Erick A Goldman

USPTO Granted Patents = 25 

 

Average Co-Inventor Count = 5.3

ph-index = 14

Forward Citations = 728(Granted Patents)


Location History:

  • Berkeley, CA (US) (2004 - 2007)
  • San Francisco, CA (US) (2002 - 2010)
  • Concord, CA (US) (2006 - 2021)

Company Filing History:

goldMedal13 out of 193 
 
Pharmacyclics, Inc.
 patents
silverMedal11 out of 850 
 
Millennium Pharmaceuticals Limited
 patents
bronzeMedal1 out of 92 
 
Cor Therapeutics, Inc.
 patents

Years Active: 2002-2021

Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents
1. 10961251 - Crystalline forms of a Bruton's tyrosine kinase inhibitor (2021-03-30),
2. 10752634 - Crystalline forms of a brutons tyrosine kinase inhibitor (2020-08-25),
3. 10294232 - Crystalline forms of a Bruton's tyrosine kinase inhibitor (2019-05-21),
4. 10294231 - Crystalline forms of a Bruton's tyrosine kinase inhibitor (2019-05-21),
5. 10266540 - Crystalline forms of a Bruton's tyrosine kinase inhibitor (2019-04-23),
6. 10125140 - Crystalline forms of a bruton's tyrosine kinase inhibitor (2018-11-13),
7. 10106548 - Crystalline forms of a Bruton's tyrosine kinase inhibitor (2018-10-23),
8. 10065968 - Crystalline forms of a bruton's tyrosine kinase inhibitor (2018-09-04),
9. 9828383 - Crystalline forms of a bruton's tyrosine kinase inhibitor (2017-11-28),
10. 9725455 - Crystalline forms of a bruton's tyrosine kinase inhibitor (2017-08-08),
11. 9713617 - Crystalline forms of a Bruton's tyrosine kinase inhibitor (2017-07-25),
12. 9540382 - Crystalline forms of a Bruton's tyrosine kinase inhibitor (2017-01-10),
13. 9296753 - Crystalline forms of a Bruton's tyrosine kinase inhibitor (2016-03-29),
14. 8691847 - Benzamides and related inhibitors of factor Xa (2014-04-08),
15. 8518977 - Benzamides and related inhibitors of factor XA (2013-08-27),

Hello! I'm thrilled to share with you the intriguing journey of inventor Erick A. Goldman and his remarkable contributions to the world of technology, particularly in the field of pharmaceuticals.

**Title: The Innovation Odyssey of Erick A. Goldman**

Introduction: Erick A. Goldman, a visionary inventor based in San Francisco, CA, is a true trailblazer in the realm of innovation. With a passion for pushing boundaries and a commitment to excellence, he has become a beacon of inspiration for upcoming inventors worldwide.

Latest Patents: Among his impressive portfolio of 25 patents, Erick A. Goldman's groundbreaking work on "Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor" stands out. This patent showcases his expertise in pharmacology, with a focus on treating autoimmune diseases, cancer, and inflammatory conditions.

Career Highlights: Erick A. Goldman has lent his exceptional talents to esteemed companies such as Pharmacyclics, Inc. and Millennium Pharmaceuticals Limited. His innovative spirit and dedication have left an indelible mark on the pharmaceutical industry, paving the way for novel treatment solutions.

Collaborations: Alongside accomplished colleagues like Mark Stephen Smyth and David Dale Wirth, Erick A. Goldman has collaborated on various groundbreaking projects. Their collective efforts have led to significant advancements in the field, benefiting countless individuals in need of cutting-edge medical interventions.

Conclusion: In conclusion, Erick A. Goldman's unwavering commitment to innovation and relentless pursuit of excellence continue to shape the landscape of technology and healthcare. His legacy serves as a testament to the transformative power of ingenuity and perseverance in driving progress and inspiring future generations of inventors.

Thank you for allowing me to delve into the remarkable story of Erick A. Goldman, a true pioneer in the world of inventions and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…